Steven Cohen Maravai Lifesciences Holdings, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,026,749 shares of MRVI stock, worth $4.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,026,749

Previous 3,519,561 70.83%

Holding current value

$4.95 Million

Previous $25.2 Million 66.14%

% of portfolio

0.02%

Previous 0.07%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $17.1 Million - $24.3 Million	-2,492,812 Reduced 70.83%	1,026,749 $8.53 Million
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $14.5 Million - $23.9 Million	2,109,199 Added 149.55%	3,519,561 $25.2 Million
Q1 2024 May 15, 2024	BUY	$5.11 - $8.76 $2.35 Million - $4.02 Million	459,162 Added 48.27%	1,410,362 $12.2 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $4.47 Million - $9.39 Million	951,200 New	951,200 $6.23 Million
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $5.56 Million - $6.9 Million	460,111 New	460,111 $5.72 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $3.11 Million - $4.59 Million	151,000 New	151,000 $3.86 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $9.15 Million - $12 Million	261,412 Added 201.88%	390,900 $16.4 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $4.77 Million - $7.85 Million	129,488 New	129,488 $6.36 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $12.7 Million - $19 Million	-493,883 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $12.1 Million - $15.2 Million	493,883 New	493,883 $13.9 Million

Others Institutions Holding MRVI

# of Institutions

235

Shares Held

141M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $634M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account